Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors—protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial)

Peer Review reports

Original Submission
14 Jun 2023	Submitted	Original manuscript
27 Jul 2023	Reviewed	Reviewer Report - Cunyun Min
27 Jul 2023	Reviewed	Reviewer Report - Alexander Gough
7 Aug 2023	Reviewed	Reviewer Report - William Lumu
29 Oct 2023	Author responded	Author comments - Ebaa Al-Ozairi
Resubmission - Version 2
29 Oct 2023	Submitted	Manuscript version 2
2 Nov 2023	Reviewed	Reviewer Report - Cunyun Min
2 Nov 2023	Reviewed	Reviewer Report - Alexander Gough
17 Dec 2023	Author responded	Author comments - Ebaa Al-Ozairi
Resubmission - Version 3
17 Dec 2023	Submitted	Manuscript version 3
18 Dec 2023	Reviewed	Reviewer Report - Cunyun Min
20 Dec 2023	Reviewed	Reviewer Report - Alexander Gough
7 Jan 2024	Author responded	Author comments - Ebaa Al-Ozairi
Resubmission - Version 4
7 Jan 2024	Submitted	Manuscript version 4
10 Jan 2024	Reviewed	Reviewer Report - Alexander Gough
12 Jan 2024	Reviewed	Reviewer Report - Cunyun Min
Resubmission - Version 5
	Submitted	Manuscript version 5
Publishing
16 Jan 2024	Editorially accepted
16 Feb 2024	Article published	10.1186/s13063-024-07930-3

Back to article page